TY - JOUR
T1 - Expression of the neurofibromatosis i gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle
AU - Norton, Karen K.
AU - Xu, Jian
AU - Gutmann, David H.
N1 - Funding Information:
We gratefully acknowledge the efforts of Dr DouglasWright in Dr William Snider’s laboratory for assistance with photodocumentation,R.Todd Geist for assistance with tissue sectioning and image analysis,Kamala Rose for assistance with the bovine tissues, Dr.Tahseen Mozaffar for his involvement in the care of the patient described in this paper, and Dr. Chung Hsu for his insights and critical review of this manuscript. DHG is supported by a grant from the NIH Clinical Investigator Award (NS-01590-04) and a generous gift from Schnuck Markets, Inc. (St Louis, MO).
PY - 1995/2
Y1 - 1995/2
N2 - Vascular pathology is an underestimated complication of neurofibromatosis 1 (NF1). Manifestations include renovascular stenosis with associated hypertension, cerebrovascular occlusion, visceral ischaemia and aneurysms of smaller arteries. This is illustrated by a woman recently evaluated in our Neurofibromatosis Program who had multiple cerebrovascular and renovascular abnormalities. To determine the contribution ofNF1expression to NF1 vasculopathy, the expression of theNF1gene product, neurofibromin, was examined in blood vessels. Neurofibromin was detected in the endothelial cell layer of rat cerebral vessels, renal arteries, and aorta by immunohistochemistry. Cultured bovine cerebral endothelial cells were found to expressNF1mRNA by RT-PCR and neurofibromin by Western immunoblotting and immunocytochemistry. Neurofibromin expression was also detected in the smooth muscle layer of the aorta but not of cerebral or renal vessels. The vascular abnormalities of NF1 are reviewed and possible pathogenesis with respect to neurofibromin expression is discussed.
AB - Vascular pathology is an underestimated complication of neurofibromatosis 1 (NF1). Manifestations include renovascular stenosis with associated hypertension, cerebrovascular occlusion, visceral ischaemia and aneurysms of smaller arteries. This is illustrated by a woman recently evaluated in our Neurofibromatosis Program who had multiple cerebrovascular and renovascular abnormalities. To determine the contribution ofNF1expression to NF1 vasculopathy, the expression of theNF1gene product, neurofibromin, was examined in blood vessels. Neurofibromin was detected in the endothelial cell layer of rat cerebral vessels, renal arteries, and aorta by immunohistochemistry. Cultured bovine cerebral endothelial cells were found to expressNF1mRNA by RT-PCR and neurofibromin by Western immunoblotting and immunocytochemistry. Neurofibromin expression was also detected in the smooth muscle layer of the aorta but not of cerebral or renal vessels. The vascular abnormalities of NF1 are reviewed and possible pathogenesis with respect to neurofibromin expression is discussed.
KW - Cancer therapy
KW - Glycollate
KW - Sodium pentosan polysulphate
UR - http://www.scopus.com/inward/record.url?scp=0029240729&partnerID=8YFLogxK
U2 - 10.1006/nbdi.1995.0002
DO - 10.1006/nbdi.1995.0002
M3 - Article
C2 - 8980005
AN - SCOPUS:0029240729
SN - 0969-9961
VL - 2
SP - 13
EP - 21
JO - Neurobiology of Disease
JF - Neurobiology of Disease
IS - 1
ER -